APLT: appliedtherapeutics.com Growth-Adjusted Market Cap to Net Income

Applied Therapeutics is implementing high-precision medicine to combat severe metabolic disorders. The fundamental PEG indicator visualizes the link between these innovations and the market price, where 0.00 expresses the metric's value today. Orphan drug status protects the business from dumping, while patients' total dependence on Govorestat ensures stable demand despite lengthy FDA reviews.

The PEG ratio relates a company's market value to its earnings growth rate, identifying assets whose price does not account for expansion dynamics. A value below one signals a fundamental undervaluation of the business. By analyzing the P/E to G growth valuation metric on GURU.Markets, an investor can uncover an asset's hidden potential. For Applied Therapeutics (APLT), this confirms the effectiveness of its ethical drug development strategy. Transparent ESG risk management supports the sustainability of this metric.